Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Inventiva ADR Representing Ord Shs IVA

Inventiva SA is a France-based company engaged in the biotechnology sector. The Company focuses on the development of therapies in the area of oncology, fibrosis and rare diseases. The Company’s pipeline comprises a number of development programs, such as Clinical Pipeline, Preclinical Pipeline, AbbVie Collaboration and Boehringer-Ingelheim collaboration. Its drug candidates target at the... see more

NDAQ:IVA - Post Discussion

Inventiva ADR Representing Ord Shs > DOG - IPO on USA a bust
View:
Post by indoubtgetout on Jul 14, 2020 1:32pm

DOG - IPO on USA a bust

IPO investors hoodwinked by underwriters.   What a poor showing....down $6 from first day of trading on USA markets.   Jefferies and Guggenheim are supposed to be good brokers but they sacrificed their clients on this one.....MOVE YOUR ACCOUNTS FROM JEFFERIES AND GUGGENHEIM...TEACH THEM A LESSON!!
Comment by Janedoodle on Oct 17, 2022 6:35am
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities